OTC Derivatives 2018 | WM Group | 25 October 2018 | Mercure Hotel and Residenz Frankfurt Messe, Voltastr. 29, 60486 Frankfurt/main, Germany

Loss-inducing OTC derivative transactions have been in large numbers for over ten years. The "Swap-jurisprudence" of the Federal Court of Justice should be mentioned as a pioneer here. Since the financial crisis, the regulatory environment for the distribution (also) of these financial instruments is constantly undergoing significant changes. The legal and judicial rights of customers and investors have been strengthened, as have their procedural rights, and the Capital Investment Schemes Act has become a strong weapon of prospectus and advisory liability since its 2012 reform. The seminar gives - starting from the now multifaceted jurisprudence of the Federal Court of Justice, the since January 2018 in the national law implemented or directly applicable "MiFID II / MiFIR Rules" and the current regulatory requirements for the OTC derivatives business - a comprehensive overview of the current state of affairs. Recognized experts give you a detailed insight into the "dos" and "don'ts" of matter.

2018 Speakers

RA Dr. Peter Clouth
Partner, Clouth & Partner

Dr. RiinBGH Desiree Dauber
Judge, Federal Court of Justice

Dr. Hanno Teuber
Syndicator & Divisional Director, Commerzbank

RA Andreas Tilp
Lawyer, Tubingen